Vertex Pharmaceuticals reported revenue of $2.99 billion for the first quarter of 2026, with its full-year guidance remaining intact. This news is being reported alongside quarterly earnings updates from other companies, some of which have seen their stock prices rise or fall significantly. The impact of Vertex Pharmaceuticals' quarterly results on its stock price is not specified in the available information.